Eribulin Mesylate 81298-3890
Product NDC
81298-3890- Manufacturer
- Long Grove Pharmaceuticals, Llc
- Dosage Form
- Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 22, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA214850
Need to source Eribulin Mesylate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Eribulin Mesylate | .5 mg/mL |
Drug Class
Microtubule Inhibition [PE]Microtubule Inhibitor [EPC]
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (81298-3890-1) / 2 mL in 1 VIAL, SINGLE-DOSE